FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CATTARUZZA, M.
Right arrow Articles by HECKER, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CATTARUZZA, M.
Right arrow Articles by HECKER, M.
(The FASEB Journal. 2000;14:991-998.)
© 2000 FASEB

Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells

MARCO CATTARUZZA, CAROLINE DIMIGEN, HANNELORE EHRENREICH* and MARKUS HECKER1

Department of Cardiovascular Physiology, University of Goettingen; and
* Max-Planck-Institute for Experimental Medicine and Departments of Neurology and Psychiatry, University of Goettingen, Germany

1Correspondence: Department of Cardiovascular Physiology, University of Goettingen, Humboldtallee 23, 37073 Goettingen, Germany. E-mail hecker{at}veg-physiol.med.uni-goettingen.de


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Growing evidence suggests that a pressure-induced increase in the synthesis of endothelin (ET-1) is involved in arterial remodeling and, as a consequence, in the manifestation of chronic hypertension. To study potential stretch-induced changes in gene expression and their functional consequences, we have cultured rat aortic smooth muscle cells (raSMC) and porcine aortic endothelial cells (PAEC) on flexible elastomer membranes. The cells were periodically stretched (up to 20% elongation, 0.5 Hz, 6 h) and the expression of prepro-ET-1 and that of the endothelin A and B receptors (ETA-R and ETB-R) were analyzed by semi-quantitative RT-PCR analysis and ELISA (ET-1). In contrast to PAEC where ET-1 synthesis was up-regulated up to eightfold on exposure to cyclic stretch, ET-1 synthesis in raSMC was decreased by more than 80% under these conditions. ETA R -mRNA expression in stretched raSMC declined to 50% whereas ETB R -mRNA levels were increased up to 10-fold. One functional consequence of this apparent shift in receptor abundance was an apoptosis-promoting action of exogenous ET-1 (10 nM), as judged by the appearance of subdiploid peaks during FACS analysis, caspase-3 activation and chromatin condensation. This ET-1-induced apoptosis appeared to be ETB-R mediated, as it was completely suppressed by the ETB-R antagonist BQ 788 but not by the ETA-R antagonist BQ 123. Moreover, raSMC derived from homozygous spotting lethal rats, which lack a functional ETB-R, showed no signs of apoptosis after exposure to cyclic strain and exogenous ET-1. These findings suggest a central role for the endothelin system in the onset of hypertension-induced remodeling in conduit arteries, which may proceed via an initial stretch-induced apoptosis of the smooth muscle cells.—Cattaruzza, M., Dimigen, C., Ehrenreich, H., Hecker, M. Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells.


Key Words: vascular remodeling • pressure overload • endothelin system • hypertrophy


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
ENDOTHELIN-1 (ET-1), THE most potent vasoconstrictor peptide known to date, is predominantly synthesized in vascular endothelial cells. The prepro-peptide is directly translated into the endoplasmic reticulum and consecutively processed by two enzymes, a furin-like protease and an endothelin-converting enzyme (ECE-1), to the biologically active 21 amino acid peptide ET-1. Besides its vasoconstrictor effect, ET-1 is a potent mitogen for vascular smooth muscle cells (VSMC) in vivo as well as in vitro (1) . Both effects appear to be mediated through activation of the G-protein-coupled type A receptor (ETA-R; 2 ), predominantly localized on these cells (3 , 4) . As the synthesis of ET-1 was reported to be increased in several hypertrophic and/or hyperplastic vascular diseases (5 , 6) , it has been implicated in the adaptive response of VSMC to an aberrant mechanical stress such as the chronic pressure overload in arterial hypertension (7 ; for review, see ref 8 ).

In contrast to the ETA-R, the ETB-R is expressed both on endothelial cells and VSMC. Its activation promotes a G-protein-mediated increase in intracellular Ca2+ similar to that of the ETA-R (9) . Its functional significance, however, is still ill-defined. Thus, activation of the ETB-R is responsible for the transient endothelium-mediated depressor response to ET-1 in vivo; on the other hand, it also promotes venoconstriction in most vascular beds. The ETB-R-mediated constriction in arteries is usually not detectable, however, or is rather weak (10 , 11) .

As with their relative functional significance, regulation of expression of the endothelin receptors is still poorly understood, but hemodynamic factors such as shear stress and wall tension may well influence their abundance in vivo, as is the case with prepro-ET-1 (12 , 13) .

Therefore, we set up an in vitro model to study the influence of cyclic strain on the expression of the endothelin system in vascular cells. Moreover, we investigated possible consequences of such a deformation-induced change in gene expression.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Materials
All laboratory chemicals were from Roth (Darmstadt, Germany) or Sigma-Aldrich (Deisenhofen, Germany). Oligonucleotides, molecular biology reagents and cell culture materials were from Life Technologies, Paisley, U.K. Horseradish peroxidase-conjugated secondary antibodies were from Sigma-Aldrich. Endothelin-1 as well as its antagonists BQ 123 and BQ 788 were from Alexis (Grünberg, Germany). The caspase-3 substrate DEVD-AFC was purchased from Biomol (Hamburg, Germany).

Cell culture
Smooth muscle cells (raSMC) from the aorta of male Wistar rats (200–250 g body weight) were isolated by the explant technique and cultured in 1 ml of Waymouth medium supplemented with 10% fetal bovine serum (FBS), 50 U/ml penicillin, 50 µg/ml streptomycin, 10 U/ml nystatin, 5 mM HEPES, and 5 mM TES, as described previously (14) .

RaSMC at passage 2 or 3 were seeded into Bioflex collagen type 1 coated 6-well plates (Flexcell Inc., Hillsborough, N.C.) and used for experiments at ~70% confluence. Their identity was confirmed after fixation with p-formaldehyde by positive immunostaining for smooth muscle {alpha}-actin with a monoclonal anti-{alpha} smooth muscle actin antibody and a secondary anti-mouse IgG-FITC conjugate from goat (Sigma-Aldrich). According to this procedure, the cultured smooth muscle cells appeared to be essentially homogeneous. RaSMC derived from wild-type (+/+), heterozygous (sl/+), and homozygous (sl/sl) spotting lethal rats (10–50 g body weight) were prepared and cultured essentially as described above. Breeding of the heterozygous animals and genotyping by reverse transcription-polymerase chain reaction (RT-PCR) analysis were performed as described previously (15) . All experiments with raSMC from these animals were conducted in a comparative fashion (i.e., each set of experiments was carried out with cells isolated from littermates).

Endothelial cells (PAEC) were isolated from porcine aortas by treatment with 1.2 U/ml dispase (Roche Diagnostics, Mannheim, Germany) in HEPES-modified Tyrode solution (total volume of 3 ml per aorta) for 7 min at 37°C. They were cultured on BioFlex collagen type I 6-well plates that had also been coated with gelatin (2 mg/ml gelatin in 0.1 M HCl for 30 min at ambient temperature) in DMEM-Ham’s F12 (1:1, v/v, Life Technologies) containing 10 U/ml nystatin, 50 U/ml penicillin, 50 µg/ml streptomycin, 5 mM HEPES, 5 mM TES, and 20% FBS until they reached confluence. They were identified by their typical cobblestone morphology and after fixation with p-formaldehyde by positive immunostaining for von Willebrand factor (vWF), with a polyclonal rabbit anti-vWF serum and a secondary anti-rabbit IgG Texas red conjugate from sheep (Sigma-Aldrich), and negative immunostaining for {alpha}-smooth muscle actin, as described before.

Administration of cyclic strain to cultured cells
If not indicated otherwise, the following standard protocol was performed. The conditioned medium of the cultured cells was exchanged against 2 ml of fresh medium supplemented as described, except for the omission of serum, 2 h before the start of the experiment. If any test compounds were to be administered, they were added 30 min earlier. After this period, the plates were mounted in a FlexerCell FX-3000 strain unit (Flexcell) placed in an incubator. RaSMC were stretched for 6 h with up to 20% elongation at 0.5 Hz. Elongation time was adjusted to 50% of total running time, resulting in cycles of 1 s of stretch and 1 s release, respectively. For PAEC, the program performed was identical except for the strain rate, which was adjusted to 12%.

Semi-quantitative RT-PCR analysis
Total RNA was isolated according to the method described by Chomczynski and Sacchi (16) . First strand cDNA synthesis from ~3 µg of total RNA was performed with Superscript reverse transcriptase (Life Technologies) according to the manufacturer’s instructions. To normalize cDNA amounts in the samples from one experiment, 2.5% of the resulting cDNA was used for performing PCR reactions for the housekeeping gene, elongation factor 2 (EF-2). PCR was performed with as few cycles as possible to clearly detect the PCR products on an ethidium bromide-stained agarose gel. According to densitometric analysis (One-Dscan Gel analysis software from Scanalytics, Billerica, Mass.) of the PCR products, cDNA volumes were adjusted for consecutive analyses. Programs and primers for the measurement of steady-state levels of mRNA of EF-2 and the other gene products were as follows: EF-2for: 5'-GAC ATC ACC AAG GGT GTG CAG-3'; EF-2rev: 5'-GCG GTC AGC ACA CTG GCA TA-3' (218 bp, position 1990 to 2207 of the human cDNA sequence); ECE-1for: 5'-CGT AGC GAT AGT CTT AGC AC-3'; ECE-1rev: 5'-GTG CCA CAC CAA AAC TAC AG-3' (529 bp, position 3815 to 4324, rat cDNA sequence); ET-1for: 5'-GGA GCT CCA GAA ACA GCT GTC-3'; ET-1rev: 5'-CTG CTG ATA AAT ACA CTT CTT TCC-3' (432 bp, position 233 to 664, rat cDNA sequence); ETAfor: 5'-TTC GTC ATG GTA CCC TTC GA-3'; ETArev: 5'-GAT ACT CGT TCC ATT CAT GG -3' (546 bp, position 713 to 1258, rat cDNA sequence); ETBfor: 5'-TTC ACC TCA GCA GGA TTC TG-3'; ETBrev: 5'-AGG TGT GGA AAG TTA GAA CG-3' (475 bp, position 1216 to 1670, rat cDNA sequence).

All PCR reactions were performed in OmnE thermocyclers from Hybaid (Heidelberg, Germany). The primers for EF-2 were kindly provided by Dr. E. Schütz, Department of Clinical Chemistry, University of Goettingen. Primers for the endothelin receptors were from Wang et al. (5) . For all primers, 58°C was established to be the optimal annealing temperature. The program performed for PCR amplification included an initial period of 2 min at 94°C, followed by a variable number of cycles of 30 s denaturation at 94°C, 30 s annealing at 58°C, and finally 60 s extension at 72°C. The program was terminated with a period of 5 min at 72°C. To be within the exponential phase of the semi-quantitative PCR reaction, the appropriate number of cycles (i. e. the phase of PCR when approximately a doubling of product was achieved with every cycle) was newly established for every set of samples.

Determination of ET-1 release
After 6–12 h of incubation, the conditioned medium of the cultured cells was collected and analyzed for its ET-1 peptide content with an ELISA kit from Amersham (Pharmacia, Freiburg, Germany) according to the manufacturer’s instructions.

Caspase-3 assay
RaSMC were harvested with a cell scraper, washed twice in Hank’s balanced salt solution (HBSS), and resuspended in 2 vol of lysis buffer (50 mM HEPESxKOH, 50 mM KCl, 5 mM EGTA, 2 mM MgCl2, 1 mM DTT, pH 7.0). Three cycles of freeze-thawing in liquid nitrogen and at 37°C in a water bath ensued, followed by extensive mixing; thereafter, the lysate was sedimented at 4°C and 1500 g for 5 min in an Eppendorf benchtop centrifuge. The supernatant was diluted 1:5 in ICE buffer [(100 mM HEPESxKOH, 10% (w/v) sucrose, 0.1% (w/v) Triton X-100, 10 mM DTT and 0.1 mg/ml bovine serum albumin, pH 7.5)] and the protein content was measured with a modified Bradford protein assay (Bio-Rad, Munich, Germany) according to the manufacturer’s instructions. The concentration of protein was adjusted to ~1 mg/ml, and 200 µl of this extract was incubated for 30 min at 30°C with 4 µl of a 1 mM solution of the caspase-3 specific substrate, DEVD-AFC (Asp-Glu-Val-Asp-7-amino-4-trifluoro-methyl-coumarin), yielding a final substrate concentration of 20 µM. After the incubation, 150 µl of each sample were transferred into a 96-well plate and the ensuing fluorescence monitored at 405 nm excitation and 510 nm emission wavelength. The fluorescence intensity of released AFC was calculated as nmoles of substrate released per milligram of protein/min by using standards of known concentration and the SOFTmax PRO-f software from Molecular Devices (Munich, Germany).

Flow cytometry
RaSMC were washed twice with HBSS and then incubated with 0.5% trypsin/0.2%EDTA (w/v, Life Technologies) for 10 min at 37°C. After complete detachment of the cells, the suspension was transferred into a centrifuge vial, 300 µl of FBS were added to inhibit the trypsin activity, and the cells were sedimented for 5 min at 4°C and 800 g. The sedimented cells were fixed with 70% ethanol and incubated for 15 min at ambient temperature. Fixed cells were harvested by centrifugation at 800 g at ambient temperature and finally resuspended in HBSS containing 200 µg/ml RNase A (Sigma-Aldrich) and 50 µg/ml of the DNA-intercalating dye propidium iodide (Sigma-Aldrich). After incubation for at least 30 min at ambient temperature, the DNA content per nucleus was analyzed by a FACS Scan flow cytometer (Becton Dickinson Co., Mansfield, Mass.) as described by Okazawa et al. (17) .

Staining of nuclear DNA with H 33342
RaSMC grown on Bioflex membranes were incubated with fixation buffer (5% formaldehyde in 145 mM NaCl, 10 mM HEPESxKOH, pH 7.5) for 20 min at room temperature. After this period the fluorescent bisbenzimide dye H 33342 (Calbiochem, Bad Soden, Germany) was added at a final concentration of 10 µg/ml and the cells were incubated for a second period of 20 min. Thereafter, the buffer was discarded, membranes were cut out with a scalpel, and mounted upside down on a microscope slide with 10 µl of mounting buffer (50% glycerol in Hank’s balanced salt solution). The slides were examined by using a video imaging system (Visitron, München, Germany). Nuclear staining intensity and morphology were evaluated optically and documented photographically.

Statistical analysis
Unless indicated otherwise, results are expressed as means ± SE of n observations with cells obtained from the aortas of different animals. Statistical evaluation was performed by Student’s t test for unpaired data, with a P value <0.05 considered statistically significant.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Stretch-induced regulation of ET-1 expression in endothelial and smooth muscle cells
To analyze the stretch-dependent expression of the prepro ET-1 gene, confluent PAEC or raSMC at 70% confluence were exposed to 12% (PAEC) or 18% (raSMC) longitudinal stretch for 6 h at 0.5 Hz. These protocols were used for all experiments described below, as these levels of cyclic strain were within the physiological range and maximum effects were obtained without visible damage to the cells. Subsequent RT-PCR analysis revealed that cyclic strain caused a marked increase in the level of preproET-1 mRNA in PAEC, whereas this was significantly decreased in raSMC (Fig. 1B ). The latter effect occurred at various levels of stretch (8–20%) and was completely reversible within 18 h after exposure of the cells to cyclic strain (not shown). At the peptide level, the amount of ET-1 released from raSMC in static culture amounted to about a quarter of that released by PAEC and was further decreased on exposure to cyclic strain, whereas the release of ET-1 from PAEC was significantly increased, albeit not to the same extent as the prepro ET-1 mRNA level (Fig. 1A ).



View larger version (34K):
[in this window]
[in a new window]
 
Figure 1. Effect of cyclic strain (6 h, 0.5 Hz, 12 and 18% elongation, respectively) on A) the amount of ET-1 released into the supernatant (n=13) and B) prepro ET-1 mRNA abundance in cultured PAEC and raSMC (n=9–16). The inserts show typical PCR analyses with elongation factor 2 (EF-2) as an internal standard. *P<0.05 vs. static control

Differential regulation of ETA-R and ETB-R expression in stretched raSMC
At the mRNA level, the ETA-R appeared to be the predominant receptor expressed in raSMC in static culture (Fig. 2 ). Exposure to cyclic strain induced a distinct decrease in ETA-R mRNA abundance (Fig. 2) , which lasted up to 6 h after termination of cyclic strain but returned to prestrain levels within 12 h (not shown). In contrast, ETB-R mRNA abundance was strongly up-regulated on exposure to cyclic strain (Fig. 2) , and this effect was maintained for at least 12 h after terminating the stretch protocol (not shown).



View larger version (25K):
[in this window]
[in a new window]
 
Figure 2. Differential effect of cyclic strain on the mRNA abundance of the ETA-R (right panel) and ETB-R (left panel) in cultured raSMC (n=17). Cells were stretched for 6 h (18%, 0.5 Hz) and steady-state mRNA levels were determined by semi-quantitative RT-PCR, with EF-2 as an internal standard as depicted in the insert. *P<0.05 vs. static control

ET-1-induced ETB-R-mediated apoptosis in stretched raSMC
To analyze the functional consequences of this stretch-induced coordinated regulation of the endothelin system at the level of transcription, we performed experiments where exogenous ET-1 (10 nM) was added to the stretched raSMC, thus mimicking the in situ situation with the endothelium having released a greater amount of ET-1 under these conditions. As judged by FACS analysis 18 h after termination of the stretch protocol, no significant alterations in total cell number or relative amounts of cells in S or G2 phase were observed in the absence of exogenous ET-1 when comparing the stretched cells to the static controls (not shown). In contrast, a prominent sub-G1 peak indicating high amounts of dying cells was detected in raSMC exposed to both cyclic strain and exogenous ET-1, but not in cells exposed individually to these stimuli (cf. Fig. 3 for the lack of effect of stretch alone). This prominent ET-1-mediated cell death was prevented by BQ 788 (Fig. 3) but not by BQ 123 (not shown) at a concentration of 0.1 µM.



View larger version (34K):
[in this window]
[in a new window]
 
Figure 3. Exemplary FACS analyses of the DNA content of raSMC after exposure to cyclic strain. Cells were incubated without control or with ET-1 (10 nM) in the absence or presence of BQ 788 (100 nM) and stretched for 6 h at 0.5 Hz and 18% elongation. After an additional 18 h incubation period under static conditions, cells were harvested by trypsinization and stained with propidium iodide. Similar findings were obtained in four additional experiments with different batches of raSMC.

To test the hypothesis of an ET-1-triggered apoptosis in stretched raSMC, caspase-3 activity (8 h after terminating the stretch protocol, Fig. 4 ) and DNA ladder formation (12–24 h after stretch termination, not shown) were analyzed. Moreover, chromatin condensation and nuclear morphology were evaluated by staining with the fluorescent DNA binding dye, H 33342 (Fig. 5 ). All four markers of apoptosis indicated that exogenous ET-1 indeed induced an ETB-R-mediated apoptosis in raSMC when the cells had been exposed to cyclic strain before, whereas either stretch or exogenous ET-1 alone did not alter the basal rate of apoptosis of these cells(112±18 and 109±15% of caspase 3 activity in static control cells, respectively, n=4).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 4. Caspase-3 activity in extracts of raSMC exposed to cyclic strain (6 h, 18% elongation, 0.5 Hz) in the presence or absence (control) of ET-1 (10 nM), ET-1 plus BQ 788 (100 nM), or ET-1 plus BQ 123 (100 nM), prepared 8 h after termination of the stretch protocol (n=6). *P<0.05 vs. control, #P<0.05 vs. ET-1



View larger version (58K):
[in this window]
[in a new window]
 
Figure 5. Chromatin condensation in raSMC exposed to cyclic strain. Cells were incubated with the test compounds at the indicated concentrations and stretched for 6 h at 0.5 Hz and 18% elongation. After an additional incubation for 18 h under static conditions, nuclei were stained with H 33342. The top panel shows the different images taken from a representative experiment; the bar chart below summarizes the data from six independent experiments with different batches of raSMC, with the number of apoptotic nuclei expressed as percentage of that in stretched cells not exposed to ET-1 (designated control, range 2–6%). P < 0.05 vs. control, P < 0.05 vs. ET-1.

Moreover, administration of BQ 788 alone afforded a protective effect on the stretched cells (30% decrease in the number of apoptotic nuclei in three of four experiments), whereas BQ 123 alone tended to enhance the rate of apoptosis (approximate doubling of the number of apoptotic nuclei in two of four experiments).

To further substantiate ETB-R-mediated apoptosis, raSMC from 2- to 3-wk-old spotting lethal rats were cultured and tested under the same experimental conditions. These animals lack a functional ETB-R due to a 301 bp deletion at the border of the first coding exon and the following intron, corresponding to the NH2 terminus of the protein (18 , 19) . Indeed, in raSMC from homozygous (sl/sl) animals, no ET-1-mediated apoptosis occurred after exposure to cyclic strain, as measured by the lack of increase in caspase-3 activity (Fig. 6C ). The overall basal level of apoptosis in these cells was lower but still within the range of raSMC isolated from wild-type (+/+) or heterozygous (sl/+) animals (Fig. 6A, B ). The pattern of ET-1-induced ETB-R-mediated apoptosis was similar in raSMC from sl/+ animals as compared to their +/+ littermates or Wistar rats, but the overall induction of caspase-3 activity in these cells was significantly lower, pointing to a gene dose effect. Moreover, neither prepro-ET-1 nor ETA-R or ETB-R expression appeared to be different in raSMC from +/+, sl/+ or sl/sl animals from the same litter, as judged by RT-PCR analysis (not shown).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 6. Caspase-3 activity in extracts of raSMC derived from A) wild-type (+/+, n=4), B) heterozygous (sl/+, n=3), and C) homozygous (sl/sl) spotting lethal rats (n=4). For experimental details refer to Fig. 4 . *P<0.05 vs. control cells, #P<0.05 vs. ET-1


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Vascular cells in vivo are exposed to two major mechanical forces. On the one hand there is endothelial cell deformation by shear stress, i.e., the viscous drag of the flowing blood, which appears to exert an overall protective effect due to the resulting increase in, for example, nitric oxide (NO) release. This in turn suppresses the mitogenesis or phenotypic alterations of smooth muscle cells in the media and usually elicits a compensatory vasodilator response (20 , 21) , an effect that may also be related to an autocrine suppression by NO of endothelial ET-1 synthesis (22) . Enhanced cyclic stretch due to a chronic increase in blood pressure, on the other hand, mainly affects the smooth muscle cells and is thought to be involved in pressure-induced vascular remodeling (23 24 25) . As an enhanced synthesis of ET-1 seems to play a role in such adaptive responses of the vessel wall, we examined whether rhythmic deformation affects expression of the endothelin system differently in cultured endothelial and smooth muscle cells.

Our findings with primary cultures of porcine endothelial cells confirm earlier results of a stretch-induced increase in ET-1 release at both the peptide and mRNA levels in bovine and human endothelial cells (26 , 27) , in human coronary arteries in situ (13) , and in rat carotid arteries after balloon angioplasty (5) . Moreover, we were recently able to demonstrate a deformation-induced increase in ET-1-synthesis in the endothelium but not in the smooth muscle of the isolated perfused carotid artery and jugular vein of the rabbit (28 , 29) . Conversely, in cultured smooth muscle cells isolated from the rat aorta, there was a marked decrease in ET-1 synthesis on exposure to cyclic strain. If this finding can be extrapolated to the in situ situation, it may represent a sensitization of the smooth muscle cells to the enhanced release of ET-1 from the endothelium.

In addition to the decrease in ET-1 synthesis, there was a change in the relative expression of the two endothelin receptors in the smooth muscle cells on exposure to cyclic strain. Whereas ETB-R mRNA levels were strongly up-regulated in response to cyclic strain, ETA-R expression was down-regulated but returned to control values within 6 h after termination of stretch. Activation of both of these receptors potentially triggers an identical biological response, as they are coupled to the same trimeric G-proteins and, for example, elevate the intracellular concentration of free calcium (30) . However, their biological effects seem to differ markedly, depending on the cell type, tissue, and possibly the intracellular compartment in which they are expressed (31) . For example, predominant ETB-R-mediated vasoconstriction is rarely seen in arteries but seems to be an alternative mechanism by which ET-1 exerts its constrictor effects in veins in vivo (32) .

Similarly, in the present study we did not observe a pro-apoptotic effect of exogenous ET-1 on nonstretched smooth muscle cells, i.e., where the ETA-R is presumably much more abundant than the ETB-R. This pro-apoptotic effect became apparent only after up-regulation of the ETB-R in response to cyclic strain, a finding supported by earlier studies describing an antiproliferative effect of stretch on cultured smooth muscle cells from porcine aorta (33) . Moreover, preliminary evidence from this laboratory (29) and two previous reports (34 , 35) suggest that in contrast to arterial smooth muscle cells, cultured and native venous smooth muscle cells do not undergo apoptosis on (rhythmic) deformation, but instead increase their rate of proliferation in a BQ 788-sensitive manner, pointing toward a phentotypic difference in the reaction of smooth muscle cells to ETB-R signaling.

That the ET-1-induced apoptosis in stretched arterial smooth muscle cells was indeed mediated through activation of the ETB-R was evidenced by two findings. First, it was completely abrogated in the presence of the ETB-R antagonist, BQ 788, whereas the ETA-R antagonist, BQ 123, had no or in some experiments even an apoptosis-promoting effect. The latter finding might be explained by the recovery of endogenous ET-1 synthesis in the cultured raSMC 12 h after termination of the stretch protocol. In addition, our data are in line with a recent report showing that arterial smooth muscle cells undergo apoptosis in experimental hypertension, an effect that is aggravated by ETA-R blockade as well (36) . Therefore, activation of the ETA-R seems to prevent rather than initiate apoptosis in arterial smooth muscle cells of the rat.

Second, smooth muscle cells isolated from the aorta of homozygous spotting lethal rats that lack a functional ETB-R did not undergo apoptosis when exposed to both ET-1 and cyclic strain. The spotting lethal rat is a crossbreed from Wistar-Kyoto rats with a rat of unknown genetic background, carrying the aforementioned sl mutation in the ETB-R gene (15 , 18 , 19) . Whereas homozygous (sl/sl) animals die within the first 4 wk of life of a megacolon due to aganglionosis resembling human Hirschsprung’s disease, heterozygous (sl/+) animals survive and seem to be completely functional with regard to the endothelin system. In fact, prepro-ET-1, ETA-R and even ETB-R mRNA levels were comparable in raSMC derived from +/+, sl/+, and sl/sl animals of the same litter; similar findings have recently been obtained with astrocytes isolated from wild-type and homzygous animals (15) .

Moreover, the finding that raSMC cultured from homozygous as well as heterozygous spotting lethal rats overall reveal a reduced susceptibility to ET-1-induced apoptosis on exposure to cyclic strain as compared to cells from wild-type animals or Wistar rats not only highlights the role of a functional ETB-R in stretch-induced apoptosis in arterial smooth muscle cells, but also points to a gene dose effect in the spotting lethal rats. Recently, such a gene dose effect has also been proposed at the level of the endothelial ETB-R with the ET-3-induced relaxant response of the basilar artery being lower in segments isolated from heterozygous animals as compared to their wild-type littermates (15) .

Apoptosis has been reported to precede and even to be a prerequisite for the development of hypertrophy in cardiomyocytes and thus ventricular remodeling (37 , 38) , reflecting not only a change in the phenotype of preexisting cells, but possibly an exchange of these terminally differentiated cells against cells with the capacity to alter their phenotype. It is tempting to speculate, therefore, that pressure-induced ETB-R-mediated apoptosis of smooth muscle cells in the media marks the onset of arterial remodeling in vivo.

In this context, the findings of the present study can be summarized as follows (Fig. 7 ). As long as blood pressure and thus cyclic strain are within the physiological range, the ETA-R is the predominant receptor expressed in arterial smooth muscle cells, mediating ET-1-induced constriction and helping in this way to preserve the existing geometry of the vessel wall. If blood pressure is elevated for prolonged periods of time above the physiological level, ETB-R expression is strongly enhanced, leading to an increased rate of smooth muscle cell death. This phenotypic alteration could mark the onset of vascular remodeling (i.e., medial hypertrophy in conduit arteries and hyperplasia in resistance-sized vessels) and reflect an adaptive response of the vessel wall to the increased pressure load. Provided that the stimulus (i.e., the increase in blood pressure) prevails, this will ultimately lead to fixation of vascular resistance and thus to the manifestation of hypertension. Although there can be no doubt that additional studies must corroborate this hypothesis, our data provide a reasonable molecular mechanism, from the physiological point of view, for these sensible adaptive responses, which often tend to exaggerate and thus become pathophysiologically relevant.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 7. Scheme illustrating the observed changes in vascular gene expression induced by cyclic strain, and their hypothetical functional consequence in vessels chronically exposed to supraphysiological levels of blood pressure. For abbreviations please refer to the text.


   ACKNOWLEDGMENTS
 
This work was supported by the Deutsche Forschungsgemeinschaft (grant no. He 1587/7–1). The authors are indebted to Dr. Bernhard Saile, Dept. of Gastroenterology, University of Goettingen, for his help with FACS analysis and to Felicia Grimm for expert technical assistance.


   FOOTNOTES
 
Received for publication July 6, 1999. Revised for publication November 2, 1999.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Janakidevi, K., Fisher, M. A., Del Vecchio, P. J., Tiruppathi, C., Figge, J., Malik, A. B. (1992) Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am. J. Physiol. 263,1295-1301
  2. Arai, H., Hori, S., Aramori, I., Ohkubo, H., Nakanishi, S. (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature (London) 348,730-732[Medline]
  3. Davenport, A. P., Kuc, R. E., Maguire, J. J., Harland, S. P. (1995) ETA receptors predominate in the human vasculature and mediate constriction. J. Cardiovasc. Pharmacol. 26,265-267
  4. Zamora, M. A., Dempsey, E. C., Walchak, S. J., Stelzner, T. J. (1993) BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am. J. Resp. Cell. Mol. Biol. 9,429-433
  5. Wang, X., Douglas, S. A., Louden, C., Vickery-Clark, L. M., Feuerstein, G. Z., Ohlstein, E. H. (1996) Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ. Res. 78,322-328[Abstract/Free Full Text]
  6. Hasdai, D., Holmes, D. R., Jr, Garratt, K. N., Edwards, W. D., Lerman, A. (1997) Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation 95,357-362[Medline]
  7. Yamazaki, T., Komuro, I., Kudoh, S., Zou, Y., Shiojima, I., Hiroi, Y., Mizuno, T., Maemura, K., Kurihara, H., Aikawa, R., Takano, H., Yazaki, Y. (1996) Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J. Biol. Chem. 271,3221-3228[Abstract/Free Full Text]
  8. Rosendorff, C. (1997) Endothelin, vascular hypertrophy, and hypertension. Cardiovasc. Drugs Ther. 10,795-802[Medline]
  9. Sakurai, T., Yanagisawa, M., Takuwa, Y., Miyazaki, H., Kimura, S., Goto, K., Masaki, T. (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (London) 348,732-735[Medline]
  10. Nilsson, T., Cantera, L., Adner, M., Edvinsson, L. (1997) Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery 40,346-351[Medline]
  11. Sharifi, A. M., Schiffrin, E. L. (1996) Endothelin receptors mediating vasoconstriction in rat pressurized small arteries. Can. J. Physiol. Pharmacol. 74,934-939[Medline]
  12. Sharefkin, J. B., Diamond, S. L., Eskin, S. G., McIntire, L. V., Dieffenbach, C. W. (1991) Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J. Vasc. Surg. 14,1-9[Medline]
  13. Wang, D. L., Wung, B. S., Peng, Y. C., Wang, J. J. (1995) Mechanical strain increases endothelin-1 gene expression via protein kinase C pathway in human endothelial cells. J. Cell. Physiol. 163,400-406[Medline]
  14. Krzesz, R., Wagner, A. H., Cattaruzza, M., Hecker, M. (1999) Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activator of transcription-1. FEBS Lett 453,191-196[Medline]
  15. Ehrenreich, H., Oldenburg, J., Hasselblatt, M., Herms, J., Dembowski, C., Löffler, B.M., Brück, W., Kamrowski-Kruck, H., Gall, S., Sirén, A. L., Schilling, L. (1999) Endothelin B receptor-defficient rats as a subtraction model to study the cerebral endothelin system. Neuroscience 91,1067-1075[Medline]
  16. Chomczynski, P., Sacchi, N. (1987) Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162,156-159[Medline]
  17. Okazawa, M., Shiraki, T., Ninomyia, H., Kobnayashi, S., Masaki, T. (1998) Endothelin-induced apoptosis of A375 human melanoma cells. J. Biol. Chem. 273,12584-12592[Abstract/Free Full Text]
  18. Gariepy, C. E., Cass, D. T., Yanagisawa, M. (1996) Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc. Natl. Acad. Sci. USA 93,867-872[Abstract/Free Full Text]
  19. Ceccherini, I., Zhang, A. L., Matera, I., Yang, G., Devoto, M., Romeo, G., Cass, D. T. (1995) Interstitial deletion of the endothelin-B receptor gene in the spotting lethal (sl) rat. Hum. Mol. Genet. 4,2089-2096[Abstract/Free Full Text]
  20. Rudic, R. D., Shesely, E. G., Maeda, N., Smithies, O., Segal, S. S., Sessa, W. C. (1998) Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 101,731-736[Medline]
  21. Noris, M., Morigi, M., Donadelli, R., Aiello, S., Foppolo, M., Todeschini, M., Orisio, S., Remuzzi, G., Remuzzi, A. (1995) Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ. Res. 76,536-543[Abstract/Free Full Text]
  22. Kourembanas, S., McQuillan, L. P., Leung, G. K., Faller, D. V. (1993) Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92,99-104
  23. Sihm, I., Schroeder, A. P., Aalkjaer, C., Holm, M., Morn, B., Mulvany, M., Thygesen, K., Lederballe, O. (1995) The relation between peripheral vascular structure, left ventricular hypertrophy, and ambulatory blood pressure in essential hypertension. Am. J. Hypertens. 8,987-996[Medline]
  24. DeBlois, D., Tea, B. S., Than, V. D., Tremblay, J., Hamet, P. (1997) Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 29,340-349[Abstract/Free Full Text]
  25. Li, J. S., Lariviere, R., Schiffrin, E. L. (1994) Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Hypertension 24,183-188[Abstract]
  26. Sumpio, B. E., Widmann, M. D. (1990) Enhanced production of endothelium-derived contracting factor by endothelial cells subjected to pulsatile stretch. Surgery 108,277-281[Medline]
  27. Macarthur, H., Warner, T. D., Wood, E. G., Corder, R., Vane, J. R. (1994) Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem. Biophys. Res. Commun. 200,395-400[Medline]
  28. Lauth, M., Berger, M. M., Cattaruzza, M., Hecker, M. (2000) Pressure-induced up-regulation of pre-pro endothelin-1 and endothelin B receptor expression in the rabbit jugular vein in situ—implications for vein graft failure?. Arterioscler. Thromb. Vasc. Biol. 20,96-103[Abstract/Free Full Text]
  29. Lauth, M., Berger, M. M., Cattaruzza, M., Hecker, M. (2000) Elevated perfusion pressure up-regualtes endothelin-1 and endothelin B receptor expression in the rabbit carotid artery. Hypertension 35,648-654[Abstract/Free Full Text]
  30. Douglas, S. A., Ohlstein, E. H. (1997) Signal transduction mechanisms mediating the vascular actions of endothelin. J. Vasc. Res. 34,152-164[Medline]
  31. Chun, M., Liyanage, U. K., Lisanti, M. P., Lodish, H. F. (1994) Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA 91,11728-11732[Abstract/Free Full Text]
  32. Moreland, S., McMullen, D. M., Delaney, C. L., Lee, V. G., Hunt, J. T. (1992) Venous smooth muscle contains vasoconstrictor ETB-like receptors. Biochem. Biophys. Res. Commun. 184,100-106[Medline]
  33. Sumpio, B. E., Banes, A. J. (1988) Response of porcine aortic smooth muscle cells to cyclic tensional deformation in culture. J. Surg. Res. 44,696-701[Medline]
  34. Predel, H. G., Yang, Z., von Segesser, L., Turina, M., Bühler, F. R., Lüscher, T. F. (1992) Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle. Lancet 340,878-879[Medline]
  35. Dethlefsen, S. M., Shepro, D., D’Amore, P. A. (1996) Comparison of the effects of mechanical stimulation on venous and arterial smooth muscle cells in vitro. J. Vasc. Res. 33,405-413[Medline]
  36. Sharifi, A. M., Schiffrin, E. L. (1997) Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism. J. Hypertens. 15,1441-1448[Medline]
  37. Teiger, E., Than, V. D., Richard, L., Wisnewsky, C., Tea, B. S., Gaboury, L., Tremblay, J., Schwartz, K., Hamet, P. (1996) Apoptosis in pressure overload-induced heart hypertrophy in the rat. J. Clin. Invest. 97,2891-2897[Medline]
  38. Condorelli, G., Morisco, C., Stassi, G., Notte, A., Farina, F., Sgaramella, G., de Rienzo, A., Roncarati, R., Trimarco, B., Lembo, G. (1999) Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99,3071-3078[Medline]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
W.-P. Cheng, H.-F. Hung, B.-W. Wang, and K.-G. Shyu
The molecular regulation of GADD153 in apoptosis of cultured vascular smooth muscle cells by cyclic mechanical stretch
Cardiovasc Res, February 1, 2008; 77(3): 551 - 559.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. SZABO, X. DENG, T. KHOMENKO, L. CHEN, G. TOLSTANOVA, K. OSAPAY, Z. SANDOR, and X. XIONG
New Molecular Mechanisms of Duodenal Ulceration
Ann. N.Y. Acad. Sci., October 1, 2007; 1113(1): 238 - 255.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Shi, Y.-J. Chiu, Y. Cho, T. A. Bullard, M. Sokabe, and K. Fujiwara
Down-regulation of ERK but not MEK phosphorylation in cultured endothelial cells by repeated changes in cyclic stretch
Cardiovasc Res, March 1, 2007; 73(4): 813 - 822.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M.-N. Raymond, C. Bole-Feysot, Y. Banno, Z. Tanfin, and P. Robin
Endothelin-1 Inhibits Apoptosis through a Sphingosine Kinase 1-Dependent Mechanism in Uterine Leiomyoma ELT3 Cells
Endocrinology, December 1, 2006; 147(12): 5873 - 5882.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Gurbanov and X. Shiliang
The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension.
Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 499 - 507.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
N. Shimojo, S. Jesmin, S. Zaedi, M. Soma, S. Maeda, I. Yamaguchi, K. Goto, and T. Miyauchi
Changes in important apoptosis-related molecules in the endothelin-1-induced hypertrophied cardiomyocytes: effect of the pretreatment with eicosapentaenoic Acid.
Experimental Biology and Medicine, June 1, 2006; 231(6): 932 - 936.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Pikkarainen, H. Tokola, R. Kerkela, M. Ilves, M. Makinen, H.-D. Orzechowski, M. Paul, O. Vuolteenaho, and H. Ruskoaho
Inverse regulation of preproendothelin-1 and endothelin-converting enzyme-1beta genes in cardiac cells by mechanical load
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1639 - R1645.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. Jamali and L. Edvinsson
Involvement of protein kinases on the upregulation of endothelin receptors in rat basilar and mesenteric arteries.
Experimental Biology and Medicine, April 1, 2006; 231(4): 403 - 411.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. Wendel, W. Kummer, L. Knels, J. Schmeck, and T. Koch
Muscular ETB Receptors Develop Postnatally and Are Differentially Distributed in Specific Segments of the Rat Vasculature
J. Histochem. Cytochem., February 1, 2005; 53(2): 187 - 196.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Cattaruzza, C. Lattrich, and M. Hecker
Focal Adhesion Protein Zyxin Is a Mechanosensitive Modulator of Gene Expression in Vascular Smooth Muscle Cells
Hypertension, April 1, 2004; 43(4): 726 - 730.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Henriksson, E. Stenman, and L. Edvinsson
Intracellular Pathways Involved in Upregulation of Vascular Endothelin Type B Receptors in Cerebral Arteries of the Rat
Stroke, June 1, 2003; 34(6): 1479 - 1483.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Ogata, M. Takahashi, S. Ueno, K. Takeuchi, T. Okada, H. Mano, S. Ookawara, K. Ozawa, B. C. Berk, U. Ikeda, et al.
Antiapoptotic Effect of Endothelin-1 in Rat Cardiomyocytes In Vitro
Hypertension, May 1, 2003; 41(5): 1156 - 1163.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Murakoshi, T. Miyauchi, Y. Kakinuma, T. Ohuchi, K. Goto, M. Yanagisawa, and I. Yamaguchi
Vascular Endothelin-B Receptor System In Vivo Plays a Favorable Inhibitory Role in Vascular Remodeling After Injury Revealed by Endothelin-B Receptor-Knockout Mice
Circulation, October 8, 2002; 106(15): 1991 - 1998.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Stenman, M. Malmsjo, E. Uddman, G. Gido, T. Wieloch, and L. Edvinsson
Cerebral Ischemia Upregulates Vascular Endothelin ETB Receptors in Rat
Stroke, September 1, 2002; 33(9): 2311 - 2316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Sanchez-Esteban, Y. Wang, L. A. Cicchiello, and L. P. Rubin
Pre- and Postnatal Lung Development, Maturation, and Plasticity: Cyclic mechanical stretch inhibits cell proliferation and induces apoptosis in fetal rat lung fibroblasts
Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L448 - L456.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. S. Filippatos, N. Gangopadhyay, O. Lalude, N. Parameswaran, S. I. Said, W. Spielman, and B. D. Uhal
Regulation of apoptosis by vasoactive peptides
Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L749 - L761.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. D. Intengan and E. L. Schiffrin
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Hypertension, September 1, 2001; 38(3): 581 - 587.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. H. Wagner, R. Krzesz, D. Gao, C. Schroeder, M. Cattaruzza, and M. Hecker
Decoy Oligodeoxynucleotide Characterization of Transcription Factors Controlling Endothelin-B Receptor Expression in Vascular Smooth Muscle Cells
Mol. Pharmacol., April 13, 2001; 58(6): 1333 - 1340.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Lauth, M. Cattaruzza, and M. Hecker
ACE Inhibitor and AT1 Antagonist Blockade of Deformation-Induced Gene Expression in the Rabbit Jugular Vein Through B2 Receptor Activation
Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 61 - 66.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Cattaruzza, I. Eberhardt, and M. Hecker
Mechanosensitive Transcription Factors Involved in Endothelin B Receptor Expression
J. Biol. Chem., September 28, 2001; 276(40): 36999 - 37003.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available